Amoy Diagnostics Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.056x

Amoy Diagnostics Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Amoy Diagnostics Co Ltd (300685) has a cash flow conversion efficiency ratio of 0.056x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥110.87 Million ≈ $16.22 Million USD) by net assets (CN¥1.97 Billion ≈ $288.79 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Amoy Diagnostics Co Ltd (2012–2025)

Cash flow conversion efficiency of Amoy Diagnostics Co Ltd from 2012 to 2025. This chart illustrates how Amoy Diagnostics Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Amoy Diagnostics Co Ltd share price for real-time trading data and today's change.

Amoy Diagnostics Co Ltd Cash Flow Conversion Ratio Explained

Amoy Diagnostics Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Amoy Diagnostics Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Amoy Diagnostics Co Ltd ranked by their cash flow conversion efficiency. Also see 300685 market cap overview for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
China Security & Fire Co Ltd Class A SHG:600654	-0.009x
Hisense Home Appliances Group Co. Ltd F:GKE	0.212x
Asia Optical Co Inc TW:3019	0.040x
CHINA FOODS UNSP.ADR/20 F:CFH0	N/A
Sichuan Chengfei Integration Technology Corp Ltd SHE:002190	0.034x
Paras Defence and Space Technologies Limited NSE:PARAS	-0.019x
BJs Restaurants Inc NASDAQ:BJRI	0.115x
JPG KLSE:5323	0.036x

Annual Cash Flow Conversion Efficiency for Amoy Diagnostics Co Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Amoy Diagnostics Co Ltd from 2012 to 2025. Review Amoy Diagnostics Co Ltd free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.06 Billion ≈ $300.85 Million	CN¥364.82 Million ≈ $53.39 Million	0.177x	-4.32%
2024-12-31	CN¥1.84 Billion ≈ $269.73 Million	CN¥341.85 Million ≈ $50.02 Million	0.185x	+5.75%
2023-12-31	CN¥1.70 Billion ≈ $249.25 Million	CN¥298.72 Million ≈ $43.71 Million	0.175x	+76.47%
2022-12-31	CN¥1.50 Billion ≈ $219.46 Million	CN¥149.04 Million ≈ $21.81 Million	0.099x	-19.06%
2021-12-31	CN¥1.37 Billion ≈ $200.42 Million	CN¥168.16 Million ≈ $24.61 Million	0.123x	-37.22%
2020-12-31	CN¥1.13 Billion ≈ $165.13 Million	CN¥220.69 Million ≈ $32.29 Million	0.196x	+16.43%
2019-12-31	CN¥902.11 Million ≈ $132.01 Million	CN¥151.52 Million ≈ $22.17 Million	0.168x	+36.02%
2018-12-31	CN¥756.74 Million ≈ $110.73 Million	CN¥93.45 Million ≈ $13.67 Million	0.123x	-12.76%
2017-12-31	CN¥649.20 Million ≈ $95.00 Million	CN¥91.89 Million ≈ $13.45 Million	0.142x	+35.41%
2016-12-31	CN¥307.91 Million ≈ $45.06 Million	CN¥32.18 Million ≈ $4.71 Million	0.105x	+35.70%
2015-12-31	CN¥247.90 Million ≈ $36.28 Million	CN¥19.10 Million ≈ $2.79 Million	0.077x	-57.03%
2014-12-31	CN¥87.54 Million ≈ $12.81 Million	CN¥15.69 Million ≈ $2.30 Million	0.179x	-17.67%
2013-12-31	CN¥39.30 Million ≈ $5.75 Million	CN¥8.56 Million ≈ $1.25 Million	0.218x	+1888.50%
2012-12-31	CN¥17.25 Million ≈ $2.52 Million	CN¥-210.00K ≈ $-30.73K	-0.012x	--

About Amoy Diagnostics Co Ltd

SHE:300685 China Diagnostics & Research

Market Cap

$1.09 Billion

CN¥7.45 Billion CNY

Market Cap Rank

#8199 Global

#1805 in China

Share Price

CN¥19.09

Change (1 day)

-3.54%

52-Week Range

CN¥16.18 - CN¥23.82

All Time High

CN¥57.70